The FY2020 Business Plan from MTP-IIGC Ltd (trading name MTPConnect) is a contracted deliverable to the Department of Industry Innovation and Science (DIIS).
Focusing on the four objectives of the Industry Growth Centre (IGC) Initiative – increasing Collaboration and Commercialisation, improving Management and Workforce Skills, improving access to Global Supply Chains and Markets and optimising the Regulatory and Policy Environment - MTPConnect forges stronger connections between research and industry and maximises opportunities for Australians to make scientific and technological breakthroughs that are successfully translated and commercialised.
Through the Growth Centre Project Fund, MTPConnect has committed $15.6 million across 36 collaborative projects, engaging over 160 consortium members.
MTPConnect also operates the Medical Research Future Fund’s $45 million BioMedTech Horizons (BMTH) program and the $22.3 million Biomedical Translation Bridge (BTB) program. The BMTH program has currently committed $10 million to support 11 projects and will deploy an additional $35 million over the next three years. BTB will launch its first round of funding in FY2020.